Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice
Medtech Dive
Tue, 01/9/24 - 10:03 pm
Tags:
JNJ, Medtech, product recalls, Megadyne, electrodes
J&J to acquire ADC drug developer Ambrx for $2B
BioPharma Dive
Mon, 01/8/24 - 11:35 am
Tags:
JNJ, Ambrx, M&A, antibody-drug conjugate, JPMHC 2024
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
Tags:
clinical trials, Beam Therapeutics, Moderna Therapeutics, Pfizer, Sanofi, Gilead Sciences, JNJ, Amylx, Roche, Alnylam Pharmaceuticals, Vertex Pharmaceuticals
Why J&J rebranded its iconic logo
Pharma Voice
Wed, 01/3/24 - 09:43 am
Tags:
rebranding, logos, JNJ
Medtech's Biggest Winners in 2023
Medical Devices and Diagnostics Industry
Thu, 12/21/23 - 11:35 am
Tags:
Medtech, CGMs, device manufacturing, JNJ, Medtronic, robotic surgery
Why heart device makers are investing in left atrial appendage closure
Medtech Dive
Wed, 12/13/23 - 09:54 am
Tags:
Medtech, left atrial appendage closure, atrial fibrillation, stroke, Boston Scientific, JNJ, Medtronic
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Fierce Pharma
Wed, 12/13/23 - 09:44 am
Tags:
ASH 2023, JNJ, Sanofi, Darzalex, Sarclisa, Multiple Myeloma
ASH23: Pharma branding, Editas’ high bar and clinical trial diversity
BioPharma Dive
Mon, 12/11/23 - 10:52 pm
Tags:
ASH 2023, JNJ, Editas Medicine, cliincal trials
As ICER places a spotlight on pharma's price hikes, J&J, Roche and more hit back
Fierce Pharma
Mon, 12/11/23 - 10:48 pm
Tags:
ICER, JNJ, Roche, drug pricing
As J&J outlines bullish pipeline goals, neuroscience pipeline takes a starring role
Fierce Biotech
Wed, 12/6/23 - 09:15 pm
Tags:
JNJ, Neuroscience, Spravato, major depressive disorder
Johnson & Johnson forecasts as much as 6% sales growth in 2024
Reuters
Tue, 12/5/23 - 10:02 am
Tags:
JNJ
J&J Hires Thousands, Invests Millions in AI-Powered Drug Discovery
BioSpace
Mon, 12/4/23 - 09:40 am
Tags:
JNJ, artificial intelligence, drug discovery, Bay Area
J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey
Fierce Pharma
Sun, 12/3/23 - 09:36 pm
Tags:
JNJ, AbbVie, Sanofi, Turkey, competition
3 medtech spinoffs that reshaped the industry in 2023, and what to expect next
Medtech Dive
Fri, 12/1/23 - 09:38 am
Tags:
Medtech, spinoffs, GE Healthcare, JNJ, Danaher, Baxter, 3M, Medtronic
J&J Becomes the Newest Player in the LAA Market
Medical Devices and Diagnostics Industry
Thu, 11/30/23 - 11:21 pm
Tags:
JNJ, M&A, Medtech, Penditure LAA
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
BioSpace
Thu, 11/30/23 - 11:20 pm
Tags:
Samsung Bioepsis, JNJ, patents, Stelara, biosimilars, SB17
J&J Sheds Light on Plans for Surgical Robot
Medical Devices and Diagnostics Industry
Wed, 11/29/23 - 11:53 am
Tags:
JNJ, Medtronic, Intuitive Surgical, robotic surgery, Medtech
J&J Seeks Expanded Use of Lung Cancer Drug Rybrevant
Yahoo/Zacks.com
Wed, 11/22/23 - 11:38 am
Tags:
JNJ, Rybevant, non-small cell lung cancer, AstraZeneca, Tagrisso
Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?
Motley Fool
Fri, 11/17/23 - 09:59 am
Tags:
JNJ, Intuitive Surgical, Medtech, robotic surgery
Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff
Fierce Biotech
Thu, 11/16/23 - 11:45 am
Tags:
Astellas, Propella Therapeutics, M&A, JNJ, Zytiga, prostate cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.